国泰疫苗与生物科技ETF联接C(017186)资产负债表
|
2025-06-30 |
2024-12-31 |
2024-06-30 |
2023-12-31 |
资产 |
银行存款 |
- |
- |
- |
- |
结算备付金 |
13,575.46 |
13,325.58 |
8,254.78 |
26,266.61 |
存出保证金 |
7,977.68 |
10,516.24 |
7,224.13 |
5,763.15 |
交易性金融资产 |
8,937,930.95 |
8,817,569.78 |
9,509,448.87 |
14,614,458.75 |
其中:股票投资 |
- |
- |
- |
- |
债券投资 |
101,270.58 |
303,950.68 |
506,614.52 |
807,532.61 |
资产支持证券投资 |
- |
- |
- |
- |
衍生金融资产 |
- |
- |
- |
- |
买入返售金融资产 |
- |
- |
- |
- |
应收证券清算款 |
- |
- |
29,039.57 |
47,698.09 |
应收利息 |
- |
- |
- |
- |
应收股利 |
- |
- |
- |
- |
应收申购款 |
14,176.59 |
13,653.54 |
3,821.14 |
18,381.84 |
其他资产 |
- |
- |
- |
- |
资产总计 |
9,556,552.36 |
9,106,214.46 |
9,734,488.51 |
14,835,788.22 |
负 债 |
短期借款 |
- |
- |
- |
- |
交易性金融负债 |
- |
- |
- |
- |
衍生金融负债 |
- |
- |
- |
- |
卖出回购金融资产款 |
- |
- |
- |
- |
应付证券清算款 |
93,345.43 |
- |
- |
- |
应付赎回款 |
53,322.48 |
41,317.23 |
166,537.45 |
108,196.37 |
应付管理人报酬 |
243.69 |
255.38 |
357.83 |
472.15 |
应付托管费 |
48.73 |
51.09 |
71.53 |
94.39 |
应付销售服务费 |
389.98 |
524.14 |
1,011.85 |
1,054.52 |
应付交易费用 |
- |
- |
- |
- |
应交税费 |
- |
- |
- |
- |
应付利息 |
- |
- |
- |
- |
应付利润 |
- |
- |
- |
- |
其他负债 |
3,223.67 |
6,080.82 |
6,592.26 |
19,810.66 |
负债合计 |
150,573.98 |
48,228.66 |
174,570.92 |
129,628.09 |
所有者权益 |
实收基金 |
15,425,983.21 |
14,468,818.28 |
16,270,291.14 |
17,654,373.19 |
未分配利润 |
-6,020,004.83 |
-5,410,832.48 |
-6,710,373.55 |
-2,948,213.06 |
所有者权益合计 |
9,405,978.38 |
9,057,985.80 |
9,559,917.59 |
14,706,160.13 |
负债及所有者权益总计 |
9,556,552.36 |
9,106,214.46 |
9,734,488.51 |
14,835,788.22 |